Chris Boerner, Board Chair and Chief Executive Officer at Bristol Myers Squibb, shared on LinkedIn:
“Science changes what’s possible and its delivery changes lives. Today, we’re putting $2.3 billion and nearly 500 jobs behind that belief.
Houston, Texas will be the site of Bristol Myers Squibb’s newest state-of-the-art manufacturing campus designed to scale alongside our pipeline and deliver medicines at the speed patients deserve.
With decades of capacity built in from day one, this facility is about getting our manufacturing ahead of breakthroughs, not scrambling to catch up with them.
And it’s a meaningful part of our $40 billion commitment to American R&D, technology and manufacturing.
The treatments of tomorrow need infrastructure that’s ready for them today. I’m excited for Houston to be that foundation and proud of what this milestone will ultimately mean for patients.”
Other articles about Bristol Myers Squibb on OncoDaily.